Physician profile
Daniel B Hoard
NPI 1003852898
$2,186.16
in general payments reported to CMS, 2019-2025
10 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $435 · 2020: $769 · 2021: $99.23 · 2022: $158 · 2023: $357 · 2024: $248 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $725.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $875.71 | 2020-2024 | Comprehensive Shoulder System, Mymobility Platform |
| Stryker Corporation | $344.78 | 2019-2025 | Variax, T2 Alpha, System 9 Cd Nxt |
| Nuvasive Specialized Orthopedics, INC. | $287.52 | 2019 | |
| Depuy Synthes Sales INC. | $285.66 | 2022-2024 | Foot Osteotomy Wedge System, Na, N/A |
| Smith+Nephew, INC. | $271.59 | 2021-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Pico 7 |
| Heron Therapeutics, INC. | $48.35 | 2025 | Zynrelef |
| Artivion, INC. | $25.44 | 2023 | Bioglue Surgical Adhesive, Vascular |
| Bioventus LLC | $18.04 | 2022 | |
| Vericel Corporation | $15.94 | 2020 | |
| Ferring Pharmaceuticals INC. | $13.13 | 2023 | Euflexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Hoard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.